Search

everythinglearnresearchcommunity

for

Search:↓

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Treating cystoid macular oedema in uveitis is difficult and risky.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Fungal infections in lab animals can interfere with research.

New treatments like JAK inhibitors show promise for reversing alopecia areata.